Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 95 Pages
Report ld: 3474112
Request Sample
Customized Report
Calcium Channel Blocker Market Size(US$)

CAGR 2025-2031
1.6%
Market Size,2031
USD 88.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Calcium Channel Blocker was estimated to be worth US$ 79.5 million in 2024 and is forecast to a readjusted size of US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.
North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.
In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.
This report aims to provide a comprehensive presentation of the global market for Calcium Channel Blocker, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Calcium Channel Blocker by region & country, by Type, and by Application.
The Calcium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Channel Blocker.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Calcium Channel Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Calcium Channel Blocker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Calcium Channel Blocker in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Calcium Channel Blocker Product Introduction
1.2 Global Calcium Channel Blocker Market Size Forecast
1.2.1 Global Calcium Channel Blocker Sales Value (2020-2031)
1.2.2 Global Calcium Channel Blocker Sales Volume (2020-2031)
1.2.3 Global Calcium Channel Blocker Sales Price (2020-2031)
1.3 Calcium Channel Blocker Market Trends & Drivers
1.3.1 Calcium Channel Blocker Industry Trends
1.3.2 Calcium Channel Blocker Market Drivers & Opportunity
1.3.3 Calcium Channel Blocker Market Challenges
1.3.4 Calcium Channel Blocker Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Calcium Channel Blocker Players Revenue Ranking (2024)
2.2 Global Calcium Channel Blocker Revenue by Company (2020-2025)
2.3 Global Calcium Channel Blocker Players Sales Volume Ranking (2024)
2.4 Global Calcium Channel Blocker Sales Volume by Company Players (2020-2025)
2.5 Global Calcium Channel Blocker Average Price by Company (2020-2025)
2.6 Key Manufacturers Calcium Channel Blocker Manufacturing Base and Headquarters
2.7 Key Manufacturers Calcium Channel Blocker Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Calcium Channel Blocker
2.9 Calcium Channel Blocker Market Competitive Analysis
2.9.1 Calcium Channel Blocker Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Calcium Channel Blocker Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcium Channel Blocker as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dihydropyridine
3.1.2 Diltiazem
3.1.3 Verapamil
3.1.4 Others
3.2 Global Calcium Channel Blocker Sales Value by Type
3.2.1 Global Calcium Channel Blocker Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Calcium Channel Blocker Sales Value, by Type (2020-2031)
3.2.3 Global Calcium Channel Blocker Sales Value, by Type (%) (2020-2031)
3.3 Global Calcium Channel Blocker Sales Volume by Type
3.3.1 Global Calcium Channel Blocker Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Calcium Channel Blocker Sales Volume, by Type (2020-2031)
3.3.3 Global Calcium Channel Blocker Sales Volume, by Type (%) (2020-2031)
3.4 Global Calcium Channel Blocker Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hypertension
4.1.2 Coronary Artery Disease
4.1.3 Arrhythmia
4.1.4 Cardiomyopathy
4.2 Global Calcium Channel Blocker Sales Value by Application
4.2.1 Global Calcium Channel Blocker Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Calcium Channel Blocker Sales Value, by Application (2020-2031)
4.2.3 Global Calcium Channel Blocker Sales Value, by Application (%) (2020-2031)
4.3 Global Calcium Channel Blocker Sales Volume by Application
4.3.1 Global Calcium Channel Blocker Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Calcium Channel Blocker Sales Volume, by Application (2020-2031)
4.3.3 Global Calcium Channel Blocker Sales Volume, by Application (%) (2020-2031)
4.4 Global Calcium Channel Blocker Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Calcium Channel Blocker Sales Value by Region
5.1.1 Global Calcium Channel Blocker Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Calcium Channel Blocker Sales Value by Region (2020-2025)
5.1.3 Global Calcium Channel Blocker Sales Value by Region (2026-2031)
5.1.4 Global Calcium Channel Blocker Sales Value by Region (%), (2020-2031)
5.2 Global Calcium Channel Blocker Sales Volume by Region
5.2.1 Global Calcium Channel Blocker Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Calcium Channel Blocker Sales Volume by Region (2020-2025)
5.2.3 Global Calcium Channel Blocker Sales Volume by Region (2026-2031)
5.2.4 Global Calcium Channel Blocker Sales Volume by Region (%), (2020-2031)
5.3 Global Calcium Channel Blocker Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Calcium Channel Blocker Sales Value, 2020-2031
5.4.2 North America Calcium Channel Blocker Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Calcium Channel Blocker Sales Value, 2020-2031
5.5.2 Europe Calcium Channel Blocker Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Calcium Channel Blocker Sales Value, 2020-2031
5.6.2 Asia Pacific Calcium Channel Blocker Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Calcium Channel Blocker Sales Value, 2020-2031
5.7.2 South America Calcium Channel Blocker Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Calcium Channel Blocker Sales Value, 2020-2031
5.8.2 Middle East & Africa Calcium Channel Blocker Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Calcium Channel Blocker Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Calcium Channel Blocker Sales Value
6.2.1 Key Countries/Regions Calcium Channel Blocker Sales Value, 2020-2031
6.2.2 Key Countries/Regions Calcium Channel Blocker Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Calcium Channel Blocker Sales Value, 2020-2031
6.3.2 United States Calcium Channel Blocker Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Calcium Channel Blocker Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Calcium Channel Blocker Sales Value, 2020-2031
6.4.2 Europe Calcium Channel Blocker Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Calcium Channel Blocker Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Calcium Channel Blocker Sales Value, 2020-2031
6.5.2 China Calcium Channel Blocker Sales Value by Type (%), 2024 VS 2031
6.5.3 China Calcium Channel Blocker Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Calcium Channel Blocker Sales Value, 2020-2031
6.6.2 Japan Calcium Channel Blocker Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Calcium Channel Blocker Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Calcium Channel Blocker Sales Value, 2020-2031
6.7.2 South Korea Calcium Channel Blocker Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Calcium Channel Blocker Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Calcium Channel Blocker Sales Value, 2020-2031
6.8.2 Southeast Asia Calcium Channel Blocker Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Calcium Channel Blocker Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Calcium Channel Blocker Sales Value, 2020-2031
6.9.2 India Calcium Channel Blocker Sales Value by Type (%), 2024 VS 2031
6.9.3 India Calcium Channel Blocker Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Pfizer Calcium Channel Blocker Product Offerings
7.1.5 Pfizer Recent Development
7.2 Aventis
7.2.1 Aventis Company Information
7.2.2 Aventis Introduction and Business Overview
7.2.3 Aventis Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Aventis Calcium Channel Blocker Product Offerings
7.2.5 Aventis Recent Development
7.3 Searle
7.3.1 Searle Company Information
7.3.2 Searle Introduction and Business Overview
7.3.3 Searle Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Searle Calcium Channel Blocker Product Offerings
7.3.5 Searle Recent Development
7.4 Bayer
7.4.1 Bayer Company Information
7.4.2 Bayer Introduction and Business Overview
7.4.3 Bayer Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Bayer Calcium Channel Blocker Product Offerings
7.4.5 Bayer Recent Development
7.5 AstraZeneca
7.5.1 AstraZeneca Company Information
7.5.2 AstraZeneca Introduction and Business Overview
7.5.3 AstraZeneca Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 AstraZeneca Calcium Channel Blocker Product Offerings
7.5.5 AstraZeneca Recent Development
7.6 Knoll Pharmaceuticals
7.6.1 Knoll Pharmaceuticals Company Information
7.6.2 Knoll Pharmaceuticals Introduction and Business Overview
7.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Product Offerings
7.6.5 Knoll Pharmaceuticals Recent Development
7.7 Wyeth-Ayerst
7.7.1 Wyeth-Ayerst Company Information
7.7.2 Wyeth-Ayerst Introduction and Business Overview
7.7.3 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Wyeth-Ayerst Calcium Channel Blocker Product Offerings
7.7.5 Wyeth-Ayerst Recent Development
7.8 AstraZeneca
7.8.1 AstraZeneca Company Information
7.8.2 AstraZeneca Introduction and Business Overview
7.8.3 AstraZeneca Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 AstraZeneca Calcium Channel Blocker Product Offerings
7.8.5 AstraZeneca Recent Development
7.9 Novartis
7.9.1 Novartis Company Information
7.9.2 Novartis Introduction and Business Overview
7.9.3 Novartis Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Novartis Calcium Channel Blocker Product Offerings
7.9.5 Novartis Recent Development
7.10 Sanofi
7.10.1 Sanofi Company Information
7.10.2 Sanofi Introduction and Business Overview
7.10.3 Sanofi Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Sanofi Calcium Channel Blocker Product Offerings
7.10.5 Sanofi Recent Development
8 Industry Chain Analysis
8.1 Calcium Channel Blocker Industrial Chain
8.2 Calcium Channel Blocker Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Calcium Channel Blocker Sales Model
8.5.2 Sales Channel
8.5.3 Calcium Channel Blocker Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Calcium Channel Blocker market size was US$ 80.61 million in 2025 and is forecast to reach a readjusted size of US$ 89.94 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
The global Calcium Channel Blocker market was valued at US$ 80.61 million in 2025 and is anticipated to reach US$ 89.94 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
The global market for Calcium Channel Blocker was estimated to be worth US$ 80.61 million in 2025 and is projected to reach US$ 89.94 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
The global Calcium Channel Blocker market is projected to grow from US$ 79.5 million in 2024 to US$ 88.7 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 143
USD 4900.00
(Single User License)
In 2024, the global market size of Calcium Channel Blocker was estimated to be worth US$ 79.5 million and is forecast to reach approximately US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
The global Calcium Channel Blocker market size was US$ 79.5 million in 2024 and is forecast to a readjusted size of US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 78
USD 4250.00
(Single User License)
The global market for Calcium Channel Blocker was valued at US$ 79.5 million in the year 2024 and is projected to reach a revised size of US$ 88.7 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published Date: 2025-01-16
Pages: 80
USD 2900.00
(Single User License)
Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published Date: 2024-04-17
Pages: 153
USD 5600.00
(Single User License)
Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published Date: 2024-04-16
Pages: 147
USD 5900.00
(Single User License)
Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published Date: 2024-04-07
Pages: 110
USD 4900.00
(Single User License)
The global Calcium Channel Blocker market size was US$ 80.61 million in 2025 and is forecast to reach a readjusted size of US$ 89.94 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
The global Calcium Channel Blocker market was valued at US$ 80.61 million in 2025 and is anticipated to reach US$ 89.94 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
The global market for Calcium Channel Blocker was estimated to be worth US$ 80.61 million in 2025 and is projected to reach US$ 89.94 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
The global Calcium Channel Blocker market is projected to grow from US$ 79.5 million in 2024 to US$ 88.7 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 143
In 2024, the global market size of Calcium Channel Blocker was estimated to be worth US$ 79.5 million and is forecast to reach approximately US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
The global Calcium Channel Blocker market size was US$ 79.5 million in 2024 and is forecast to a readjusted size of US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 78
The global market for Calcium Channel Blocker was valued at US$ 79.5 million in the year 2024 and is projected to reach a revised size of US$ 88.7 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published: 2025-01-16
Pages: 80
Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published: 2024-04-17
Pages: 153
Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published: 2024-04-16
Pages: 147
Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published: 2024-04-07
Pages: 110
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now